ID

31768

Beschreibung

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01399645

Link

https://clinicaltrials.gov/show/NCT01399645

Stichworte

Versionen (2)
  1. 26/09/2018 26/09/2018 -
  2. 27/09/2018 27/09/2018 - Sarah Riepenhausen
Rechteinhaber

Centre hospitalier de l'Université de Montréal (CHUM)

Hochgeladen am

27 septembre 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Nonalcoholic Fatty Liver Disease NCT01399645

Englisch

Eligibility Nonalcoholic Fatty Liver Disease NCT01399645

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
are 18 y.o. or older at screening (first visit),
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
are ambulatory,
Beschreibung

Ambulatory

Datentyp

boolean

Alias
UMLS CUI [1]
C0439841
are known for type 2 diabetes with criteria of failure of metformin monotherapy, metformin-sulfonylurea, metformin-repaglinide combined therapy defined as hba1c ≥6.5,
Beschreibung

Diabetes typ 2, failure therapy with metformin, metformin-sulfonylurea, metformin-repaglinide; HBA1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C1272705
UMLS CUI [2,2]
C0025598
UMLS CUI [3,1]
C1272705
UMLS CUI [3,2]
C0025598
UMLS CUI [3,3]
C0038766
UMLS CUI [3,4]
C0205195
UMLS CUI [4,1]
C1272705
UMLS CUI [4,2]
C0025598
UMLS CUI [4,3]
C0246689
UMLS CUI [4,4]
C0205195
UMLS CUI [5]
C0202054
abdominal girth > 94 cm for men and > 80 cm for women,
Beschreibung

Abdominal girth

Datentyp

boolean

Alias
UMLS CUI [1]
C0232501
understand french or english instruction,
Beschreibung

Language comprehension in french/english

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0233733
UMLS CUI [1,2]
C0376246
UMLS CUI [2,1]
C0233733
UMLS CUI [2,2]
C0376245
able to comprehend and willingness to provide voluntary consent.
Beschreibung

Comprehension and Willingness to consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
have any contra-indications for mri (such as metallic implants, pacemaker or claustrophobia),
Beschreibung

Contraindication for MRI (metallic implants, pacemaker, claustrophobia)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C0522473
UMLS CUI [2,1]
C0021102
UMLS CUI [2,2]
C2986473
UMLS CUI [3]
C0848753
UMLS CUI [4]
C0008909
have type 1 diabetes or have had episodes of ketoacidosis,
Beschreibung

Diabetes typ 1, episodes of ketoacidosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C0332189
UMLS CUI [2,2]
C0220982
have any major debilitating disease including malignant disorders
Beschreibung

Severe disease, malignant disorder

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0006826
have had, within the last 6 months, evidence of significant heart disease or stroke, including myocardial infarction, unstable angina, coronary bypass and/or percutaneous transluminal coronary angioplasty (ptca), congestive heart failure (new york heart association class iii-iv), or severe ischemic disease,
Beschreibung

significant heart disease or stroke (myocardial infarction, unstable angina, coronary bypass and/or ptca, congestive heart failure (NYHA iii-iv), severe ischemic disease)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0750502
UMLS CUI [1,2]
C0018799
UMLS CUI [1,3]
C0332185
UMLS CUI [2,1]
C0038454
UMLS CUI [2,2]
C0332185
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0002965
UMLS CUI [5,1]
C0010055
UMLS CUI [5,2]
C2936173
UMLS CUI [6,1]
C0018802
UMLS CUI [6,2]
C1275491
UMLS CUI [7,1]
C0205082
UMLS CUI [7,2]
C0151744
patients having received insulin within 3 months prior to screening,
Beschreibung

Received insulin 3 months prior to screening

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0332185
have a serum creatine above >150 mmol/l or estimated gfr < 30 ml/min,
Beschreibung

Serum creatine, estimated GFR

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C4524116
women seeking pregnancy,
Beschreibung

Pregnancy planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0032992
have a history of chronic liver disease other than nafld, including hbv and hcv infection, hemochromatosis, wilson's disease, alpha-1-antitrypsin deficiency, autoimmune hepatitis,
Beschreibung

Other chronic liver diseases than NAFLD (HBV, HCV, hemochromatosis, wilson's disease, alpha-1-antitrypsin deficiency, autoimmune hepatitis)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0341439
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0400966
UMLS CUI [2]
C2242656
UMLS CUI [3]
C1698259
UMLS CUI [4]
C0018995
UMLS CUI [5]
C0019202
UMLS CUI [6]
C0221757
UMLS CUI [7]
C0241910
current or previous use of oral or injectable corticosteroids,
Beschreibung

Current/previous oral/injectable corticosteroids use

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442027
UMLS CUI [1,2]
C0001617
UMLS CUI [1,3]
C0521116
UMLS CUI [2,1]
C0442027
UMLS CUI [2,2]
C0001617
UMLS CUI [2,3]
C0205156
UMLS CUI [3,1]
C0086466
UMLS CUI [3,2]
C0001617
UMLS CUI [3,3]
C0521116
UMLS CUI [4,1]
C0086466
UMLS CUI [4,2]
C0001617
UMLS CUI [4,3]
C0205156
have excessive alcohol intake, defined as a daily limit of 30 g (3 drinks) for men and 20 g (2 drinks) for women.
Beschreibung

Alcohol abuse

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085762
UMLS CUI [1,2]
C0560578
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Nonalcoholic Fatty Liver Disease NCT01399645

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
are 18 y.o. or older at screening (first visit),
boolean
C0001779 (UMLS CUI [1])
Ambulatory
Item
are ambulatory,
boolean
C0439841 (UMLS CUI [1])
Diabetes typ 2, failure therapy with metformin, metformin-sulfonylurea, metformin-repaglinide; HBA1c
Item
are known for type 2 diabetes with criteria of failure of metformin monotherapy, metformin-sulfonylurea, metformin-repaglinide combined therapy defined as hba1c ≥6.5,
boolean
C0011860 (UMLS CUI [1])
C1272705 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1272705 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C0038766 (UMLS CUI [3,3])
C0205195 (UMLS CUI [3,4])
C1272705 (UMLS CUI [4,1])
C0025598 (UMLS CUI [4,2])
C0246689 (UMLS CUI [4,3])
C0205195 (UMLS CUI [4,4])
C0202054 (UMLS CUI [5])
Abdominal girth
Item
abdominal girth > 94 cm for men and > 80 cm for women,
boolean
C0232501 (UMLS CUI [1])
Language comprehension in french/english
Item
understand french or english instruction,
boolean
C0233733 (UMLS CUI [1,1])
C0376246 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Comprehension and Willingness to consent
Item
able to comprehend and willingness to provide voluntary consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Contraindication for MRI (metallic implants, pacemaker, claustrophobia)
Item
have any contra-indications for mri (such as metallic implants, pacemaker or claustrophobia),
boolean
C0024485 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C0021102 (UMLS CUI [2,1])
C2986473 (UMLS CUI [2,2])
C0848753 (UMLS CUI [3])
C0008909 (UMLS CUI [4])
Diabetes typ 1, episodes of ketoacidosis
Item
have type 1 diabetes or have had episodes of ketoacidosis,
boolean
C0011854 (UMLS CUI [1])
C0332189 (UMLS CUI [2,1])
C0220982 (UMLS CUI [2,2])
Severe disease, malignant disorder
Item
have any major debilitating disease including malignant disorders
boolean
C0012634 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0006826 (UMLS CUI [2])
significant heart disease or stroke (myocardial infarction, unstable angina, coronary bypass and/or ptca, congestive heart failure (NYHA iii-iv), severe ischemic disease)
Item
have had, within the last 6 months, evidence of significant heart disease or stroke, including myocardial infarction, unstable angina, coronary bypass and/or percutaneous transluminal coronary angioplasty (ptca), congestive heart failure (new york heart association class iii-iv), or severe ischemic disease,
boolean
C0750502 (UMLS CUI [1,1])
C0018799 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0038454 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0010055 (UMLS CUI [5,1])
C2936173 (UMLS CUI [5,2])
C0018802 (UMLS CUI [6,1])
C1275491 (UMLS CUI [6,2])
C0205082 (UMLS CUI [7,1])
C0151744 (UMLS CUI [7,2])
Received insulin 3 months prior to screening
Item
patients having received insulin within 3 months prior to screening,
boolean
C0021641 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Serum creatine, estimated GFR
Item
have a serum creatine above >150 mmol/l or estimated gfr < 30 ml/min,
boolean
C0201976 (UMLS CUI [1])
C4524116 (UMLS CUI [2])
Pregnancy planned
Item
women seeking pregnancy,
boolean
C0032992 (UMLS CUI [1])
Other chronic liver diseases than NAFLD (HBV, HCV, hemochromatosis, wilson's disease, alpha-1-antitrypsin deficiency, autoimmune hepatitis)
Item
have a history of chronic liver disease other than nafld, including hbv and hcv infection, hemochromatosis, wilson's disease, alpha-1-antitrypsin deficiency, autoimmune hepatitis,
boolean
C0341439 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0400966 (UMLS CUI [1,3])
C2242656 (UMLS CUI [2])
C1698259 (UMLS CUI [3])
C0018995 (UMLS CUI [4])
C0019202 (UMLS CUI [5])
C0221757 (UMLS CUI [6])
C0241910 (UMLS CUI [7])
Current/previous oral/injectable corticosteroids use
Item
current or previous use of oral or injectable corticosteroids,
boolean
C0442027 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
C0521116 (UMLS CUI [1,3])
C0442027 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
C0086466 (UMLS CUI [3,1])
C0001617 (UMLS CUI [3,2])
C0521116 (UMLS CUI [3,3])
C0086466 (UMLS CUI [4,1])
C0001617 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
Alcohol abuse
Item
have excessive alcohol intake, defined as a daily limit of 30 g (3 drinks) for men and 20 g (2 drinks) for women.
boolean
C0085762 (UMLS CUI [1,1])
C0560578 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video